Quinapril hydrochloride | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Quinapril Hydrochloride
Health Canada Patents

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

Contact Supplier

IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

Contact Supplier

medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.

Contact Supplier

Coral

Contact Supplier

ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

Contact Supplier

Quinapril hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

14 API Suppliers, 11 USDMF, 4 CEP/COS, 4 EU WC, 5 NDC API, 6 Listed Suppliers, $ API Reference Price

14 API Suppliers
11 USDMF
4 CEP/COS
4 EU WC
5 NDC API
6 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

200 FDF Dossiers, 77 FDA Orange Book, 90 Europe, 4 Canada, 3 Australia, 26 South Africa

200 FDF Dossiers
77 FDA Orange Book
90 Europe
4 Canada
3 Australia
26 South Africa

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 9 SPI Pharma, 13 DKSH, 1 Pharm-RX Chemical, 10 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 4 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 31 BASF, 1 CD Formulation, 1 Clariant, 10 Corel Pharma Chem, 4 DFE Pharma, 1 Esteem Industries, 1 Finar, 9 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 5 Ideal Cures, 2 Ingredion Pharma Solutions, 22 Kerry, 1 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 5 Novo Excipients, 3 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 15 Roquette, 7 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 9 Sigachi Industries, 2 Silverline Chemicals, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

65 Fillers, Diluents & Binders, 49 Coating Systems & Additives, 31 Direct Compression, 31 Granulation, 29 Thickeners and Stabilizers, 28 Controlled & Modified Release, 22 Disintegrants & Superdisintegrants, 17 Solubilizers, 16 Lubricants & Glidants, 14 Co-Processed Excipients, 13 Topical, 12 Chewable & Orodispersible Aids, 12 Film Formers & Plasticizers, 10 Taste Masking, 9 Rheology Modifiers, 9 Empty Capsules, 7 API Stability Enhancers, 6 Parenteral, 5 Emulsifying Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 2 Surfactant & Foaming Agents

65 Fillers, Diluents & Binders
49 Coating Systems & Additives
31 Direct Compression
31 Granulation
29 Thickeners and Stabilizers
28 Controlled & Modified Release
22 Disintegrants & Superdisintegrants
17 Solubilizers
16 Lubricants & Glidants
14 Co-Processed Excipients
13 Topical
12 Chewable & Orodispersible Aids
12 Film Formers & Plasticizers
10 Taste Masking
9 Rheology Modifiers
9 Empty Capsules
7 API Stability Enhancers
6 Parenteral
5 Emulsifying Agents
5 Coloring Agents
4 Vegetarian Capsules
2 Surfactant & Foaming Agents

DIGITAL CONTENT

16 News #PharmaBuzz

16 News #PharmaBuzz

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 53 Regulatory FDF Prices

8 US Medicaid Prescriptions
53 Regulatory FDF Prices

MARKET PLACE

7 APIs, 1 FDF Dossiers

7 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 Health Canada Patents

8 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 Others

3 EDQM
2 Others

$ API Ref.Price (USD/KG) : 735 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

8 All

01 8Pfizer Canada Inc.

filter Patent Reset all filters

8 All

01 41331615

02 41341330

filter Product Reset all filters

8 All

01 8Quinapril Hydrochloride

filter Dosage Reset all filters

8 All

01 8Tablet

filter Exp Date Reset all filters

8 All

01 42011-08-23

02 42019-01-01

Product Main Page

01

Pfizer Canada Inc.

Quinapril Hydrochloride

Formnext Forum

Not Confirmed

Pfizer Canada Inc.

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-01-01

Date Granted : 2002-01-01

Quinapril Hydrochloride

Brand Name : ACCUPRIL

Patent Number : 1341330

Filing Date : 1981-09-30

Strength per Unit : 5mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-01-01

Date Granted : 2002-01-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Pfizer Canada Inc.

Quinapril Hydrochloride

Formnext Forum

Not Confirmed

Pfizer Canada Inc.

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-08-23

Date Granted : 1994-08-23

Quinapril Hydrochloride

Brand Name : ACCUPRIL

Patent Number : 1331615

Filing Date : 1981-09-30

Strength per Unit : 5mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-08-23

Date Granted : 1994-08-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Pfizer Canada Inc.

Quinapril Hydrochloride

Formnext Forum

Not Confirmed

Pfizer Canada Inc.

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-01-01

Date Granted : 2002-01-01

Quinapril Hydrochloride

Brand Name : ACCUPRIL

Patent Number : 1341330

Filing Date : 1981-09-30

Strength per Unit : 10mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-01-01

Date Granted : 2002-01-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Pfizer Canada Inc.

Quinapril Hydrochloride

Formnext Forum

Not Confirmed

Pfizer Canada Inc.

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-08-23

Date Granted : 1994-08-23

Quinapril Hydrochloride

Brand Name : ACCUPRIL

Patent Number : 1331615

Filing Date : 1981-09-30

Strength per Unit : 10mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-08-23

Date Granted : 1994-08-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Pfizer Canada Inc.

Quinapril Hydrochloride

Formnext Forum

Not Confirmed

Pfizer Canada Inc.

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-01-01

Date Granted : 2002-01-01

Quinapril Hydrochloride

Brand Name : ACCUPRIL

Patent Number : 1341330

Filing Date : 1981-09-30

Strength per Unit : 20mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-01-01

Date Granted : 2002-01-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Pfizer Canada Inc.

Quinapril Hydrochloride

Formnext Forum

Not Confirmed

Pfizer Canada Inc.

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-08-23

Date Granted : 1994-08-23

Quinapril Hydrochloride

Brand Name : ACCUPRIL

Patent Number : 1331615

Filing Date : 1981-09-30

Strength per Unit : 20mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-08-23

Date Granted : 1994-08-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Pfizer Canada Inc.

Quinapril Hydrochloride

Formnext Forum

Not Confirmed

Pfizer Canada Inc.

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-01-01

Date Granted : 2002-01-01

Quinapril Hydrochloride

Brand Name : ACCUPRIL

Patent Number : 1341330

Filing Date : 1981-09-30

Strength per Unit : 40mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-01-01

Date Granted : 2002-01-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Pfizer Canada Inc.

Quinapril Hydrochloride

Formnext Forum

Not Confirmed

Pfizer Canada Inc.

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-08-23

Date Granted : 1994-08-23

Quinapril Hydrochloride

Brand Name : ACCUPRIL

Patent Number : 1331615

Filing Date : 1981-09-30

Strength per Unit : 40mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-08-23

Date Granted : 1994-08-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!